These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7003806)

  • 1. Heparin-prostacyclin interactions: heparin does not modify the prostacyclin induced relaxation of coronary vasculature.
    Eldor A; Allan G; Weksler BB
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):719-23. PubMed ID: 7003806
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of prostacyclin and heparin on hemodialyses in dogs.
    Gross M; Bush H; McTigue H; Hamburger RJ; Flamenbaum W
    Prostaglandins; 1981 Jun; 21(6):879-88. PubMed ID: 7027320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin can replace heparin in haemodialysis in dogs.
    Woods HF; Ash G; Weston MJ; Bunting S; Moncada S; Vane JR
    Lancet; 1978 Nov; 2(8099):1075-7. PubMed ID: 82090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of action of coronary arterial relaxation by prostacyclin.
    Holzmann S; Kukovetz WR; Schmidt K
    J Cyclic Nucleotide Res; 1980; 6(6):451-60. PubMed ID: 6163806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin relaxes the longitudinal muscle of human isolated stomach and antagonizes contractions to some prostanoids [proceedings].
    Bennett A; Sanger GJ
    J Physiol; 1980 Jan; 298():45P-46P. PubMed ID: 6987380
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostacyclin increases cAMP in coronary arteries.
    Kukovetz WR; Holzmann S; Wurm A; Pöch G
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):469-76. PubMed ID: 231612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prostaglandins E2, I2 and F2 alpha on the tone of isolated coronary arteries from alloxan-diabetic dogs.
    Palik I; Koltai MZ; Hadházy P; Malomvölgyi B; Wagner M; Pogátsa G
    Prostaglandins Leukot Med; 1982 Jun; 8(6):607-14. PubMed ID: 7051047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin eliminates the bioincompatibility of charcoal haemoperfusion.
    Weston MJ; Woods HF; Bunting S; Moncada S; Vane JR
    Proc Eur Dial Transplant Assoc; 1979; 16():225-31. PubMed ID: 398492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries.
    Schrör K; Rösen P
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jan; 306(1):101-3. PubMed ID: 218118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockage of partially obstructed coronary arteries with platelet thrombi: comparison between its prevention with cyclooxygenase inhibitors versus prostacyclin.
    Aiken JW; Shebuski RJ; Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 7():635-9. PubMed ID: 6245568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on prostaglandins F2 alpha, I2, and indomethacin on isolated coronary arteries from healthy and alloxan-diabetic dogs.
    Palik I; Hadházy P; Magyar K; Malomvölgyi B; Wagner M; Pogátsa G
    Experientia; 1981; 37(8):863-4. PubMed ID: 7026273
    [No Abstract]   [Full Text] [Related]  

  • 12. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
    Coppe D; Sobel M; Seamans L; Levine F; Salzman E
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostacyclin (PGI2) is a weak contractor of coronary arteries of the pig.
    Dusting GJ; Moncada S; Vane JR
    Eur J Pharmacol; 1977 Oct; 45(3):301-4. PubMed ID: 336382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil adhesiveness during prostacyclin and heparin hemodialysis.
    Spagnuolo PJ; Bass SH; Smith MC; Danviriyasup K; Dunn MJ
    Blood; 1982 Oct; 60(4):924-9. PubMed ID: 7052162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostacyclin: a solution to some problems of extracorporeal circulation. Experiments in greyhounds.
    Longmore DB; Bennett G; Gueirrara D; Smith M; Bunting S; Moncada S; Reed P; Read NG; Vane JR
    Lancet; 1979 May; 1(8124):1002-5. PubMed ID: 86720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin neutralization of PGI2: effects upon platelets.
    Saba HI; Saba SR; Blackburn CA; Hartmann RC; Mason RG
    Science; 1979 Aug; 205(4405):499-501. PubMed ID: 377493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostacyclin--antiarrhythmic or arrhythmogenic? Comparison of the effects of intravenous and intracoronary prostacyclin and ZK36374 during coronary artery occlusion and reperfusion in anaesthetised greyhounds.
    Coker SJ; Parratt JR
    J Cardiovasc Pharmacol; 1983; 5(4):557-67. PubMed ID: 6193351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissimilar effects of prostacyclin, prostaglandin E1, and prostaglandin E2 on myocardial infarct size after coronary occlusion in conscious dogs.
    Jugdutt BI; Hutchins GM; Bulkley BH; Becker LC
    Circ Res; 1981 Sep; 49(3):685-700. PubMed ID: 7020976
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of prostacyclin on myogenic activity and adrenergic neuroeffector interaction in isolated canine veins.
    Herman AG; Verbeuren TJ; Moncada S; Vane JR; Vanhoutte PM
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):340-1. PubMed ID: 354538
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.